© Reuters. FILE PHOTO: In this illustration, medical vials and syringes are seen in front of the J&J logo
(Reuters) – Johnson & Johnson (NYSE 🙂 is facing unexpected delays in manufacturing its coronavirus vaccine and may not be able to deliver the doses it promised the federal government for the spring, the New York Times reported Wednesday. US federal officials have been told that J&J is up to two months behind the original production schedule and will not catch up until the end of April, when it was supposed to have delivered more than 60 million doses. the NYT reported, citing people familiar with the situation. (https://nyti.ms/38EX4n9) The company and the U.S. Department of Health and Human Services did not immediately respond to Reuters requests for comment. Earlier this week, the J&J CEO said the company was on track to have close to 1 billion doses of COVID-19 vaccine by the end of 2021.